Haileyesus Getahun MD, MPH, PhD.
@hygetahun
CEO of https://t.co/10dOgkwOmD working on Global South health issues & equity. Formerly Director of Global Coordination & Quadripartite Joint Secretariat on AMR @WHO
ID:47101165
http://www.HeDPAC.org 14-06-2009 14:34:51
3,1K Tweets
4,4K Followers
910 Following
Thank you Jarbas Barbosa for the fruitful discussion with you and your team to seek synergy and impact in HeDPAC priorities of #HealthWorkforce #HealthSystem and local manufacturing of medical products through catalysing high level political engagement and local ownership.
In many ways, the story of the fraught #PandemicAccord negotiations is the story of Henrietta Lacks — the African American patient whose cancer cells were used in research for years without her family’s knowledge — retold on a global stage. washingtonpost.com/health/2024/04…
Powerful intervention from Professor Senait Fisseha at #WBGMeetings about the changing global health order and leadership of the Global South.
Today we agreed to commence the end to end process of repurposing the off-patent anti-fungal drug Terbinafine for #breastcancer & #prostatecancer including proof of concept clinical trials in Barbados & Rwanda through south-south cooperation. Thank you Mia Amor Mottley for the
The Global Leaders Group on AMR chaired by Mia Amor Mottley has just released its first report on #AMR with 10 recommendations for UN member states to consider for the #UNGA #HLM . The report estimates that AMR would cost the world every year US$ 412 billion in additional healthcare costs plus US$
The GLG thanked Haileyesus Getahun MD, MPH, PhD. for his strong & strategic leadership of the GLG Secretariat since 2020 & contribution to key achievements as founding director of the Quadripartite Joint Secretariat over the past 5 yrs. The GLG wishes him best for his new role leading HeDPAC
Minister Dr Sabin Nsanzimana is in Cuba on an official visit to discuss bilateral health cooperation with @MINISAPCuba. He was received by José Angel Portal Miranda & signed cooperation agreements to exchange medical expertise, health education, scientific research & biopharma development.